• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Upfront Adjuvant Immunotherapy of Replication Repair-Deficient Pediatric Glioblastoma With Chemoradiation-Sparing Approach.

作者信息

Larkin Trisha, Das Anirban, Bianchi Vanessa, Sudhaman Sumedha, Chung Jiil, Alsafwani Noor, Negm Logine, Yachnis Anthony, Blatt Jason, Hawkins Cynthia, Bouffet Eric, Tabori Uri, Gururangan Sridharan

机构信息

Department of Pediatrics, UF Health Shands Hospital, Gainesville, FL.

Department of Oncology, St Jude Children's Research Hospital, Memphis, TN.

出版信息

JCO Precis Oncol. 2021 Nov;5:1426-1431. doi: 10.1200/PO.21.00153.

DOI:10.1200/PO.21.00153
PMID:34994637
Abstract
摘要

相似文献

1
Upfront Adjuvant Immunotherapy of Replication Repair-Deficient Pediatric Glioblastoma With Chemoradiation-Sparing Approach.采用保留放化疗方法对复制修复缺陷型小儿胶质母细胞瘤进行 upfront 辅助免疫治疗。
JCO Precis Oncol. 2021 Nov;5:1426-1431. doi: 10.1200/PO.21.00153.
2
Letter: Survival With Glioblastoma Multiforme and the Timing of Chemoradiation.信函：多形性胶质母细胞瘤的生存情况与放化疗时机
Neurosurgery. 2016 Feb;78(2):E313-4. doi: 10.1227/NEU.0000000000001077.
3
In Reply: Survival With Glioblastoma Multiforme and the Timing of Chemoradiation.回复：多形性胶质母细胞瘤的生存情况与放化疗时机
Neurosurgery. 2016 Feb;78(2):E315. doi: 10.1227/NEU.0000000000001078.
4
The impact of timing of adjuvant therapy on survival for patients with glioblastoma: An analysis of the National Cancer Database.辅助治疗时机对胶质母细胞瘤患者生存的影响：国家癌症数据库分析。
J Clin Neurosci. 2019 Aug;66:92-99. doi: 10.1016/j.jocn.2019.05.013. Epub 2019 May 16.
5
Upfront surgery and pathological stage-based adjuvant chemoradiation strategy in locally advanced esophageal squamous cell carcinoma.局部进展期食管鳞癌的 upfront 手术和基于病理分期的辅助放化疗策略。
Sci Rep. 2018 Feb 1;8(1):2180. doi: 10.1038/s41598-018-20654-0.
6
Delay in adjuvant chemoradiation impacts survival outcome in glioblastoma multiforme patients.辅助放化疗延迟影响多形性胶质母细胞瘤患者的生存结局。
Acta Oncol. 2020 Mar;59(3):320-323. doi: 10.1080/0284186X.2019.1672893. Epub 2019 Oct 1.
7
Impact of Timing of Adjuvant Chemoradiation for Glioblastoma in a Large Hospital Database.大型医院数据库中胶质母细胞瘤辅助放化疗时机的影响。
Neurosurgery. 2018 Nov 1;83(5):915-921. doi: 10.1093/neuros/nyx497.
8
Commentary on "Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme".关于“多形性胶质母细胞瘤辅助放化疗期间高血糖发作的强烈不良预后影响”的评论
Strahlenther Onkol. 2015 Mar;191(3):281-2. doi: 10.1007/s00066-014-0788-9.
9
Clinical Features and Prognostic Factors of Pediatric Glioblastoma: Report of 38 Cases.儿童胶质母细胞瘤的临床特征及预后因素：38 例报告。
World Neurosurg. 2021 Sep;153:e105-e111. doi: 10.1016/j.wneu.2021.06.033. Epub 2021 Jun 12.
10
The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma.同步放化疗时机对新诊断胶质母细胞瘤患者的影响
Neurosurgery. 2015 Aug;77(2):248-53; discussion 253. doi: 10.1227/NEU.0000000000000766.

引用本文的文献

1
An update on central nervous system tumors in germline replication-repair deficiency syndromes.种系复制修复缺陷综合征中枢神经系统肿瘤的最新进展
Neurooncol Adv. 2024 Jun 19;6(1):vdae102. doi: 10.1093/noajnl/vdae102. eCollection 2024 Jan-Dec.
2
Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome.针对患有遗传性错配修复缺陷综合征的同胞中四种恶性肿瘤的精准免疫肿瘤学方法。
NPJ Precis Oncol. 2024 May 21;8(1):110. doi: 10.1038/s41698-024-00597-8.
3
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium.
联合免疫疗法改善抗 PD-1 单药治疗失败的复制修复缺陷（RRD）高级别胶质瘤的预后：来自国际 RRD 联盟的报告。
Cancer Discov. 2024 Feb 8;14(2):258-273. doi: 10.1158/2159-8290.CD-23-0559.
4
Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency.高突变负荷和错配修复缺陷的儿科癌症中纳武单抗的疗效。
Clin Cancer Res. 2023 Dec 1;29(23):4770-4783. doi: 10.1158/1078-0432.CCR-23-0411.
5
Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908.尼伏鲁单抗联合或不联合伊匹单抗用于治疗儿童高级别中枢神经系统恶性肿瘤：安全性、疗效、生物标志物和药代动力学- CheckMate 908。
Neuro Oncol. 2023 Aug 3;25(8):1530-1545. doi: 10.1093/neuonc/noad031.
6
Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome-associated glioma.纳武单抗治疗林奇综合征相关胶质瘤的持久获益及TCR克隆性变化
Ther Adv Med Oncol. 2022 Jun 8;14:17588359221100863. doi: 10.1177/17588359221100863. eCollection 2022.